Report
Oliver Metzger

Fresenius SE & CO KGaA : DRG inflator set to increase to attractive level, but still too low

>DRG inflator at attractive level - The budget of hospitals consists of a volume and a price component. The purpose of diagnosis related groups (DRG) is to identify the pricing component of products and services that a hospital provides, annual adaptations of the DRG inflator reflect cost positions for the operations of hospitals. The price increase for hospital services in Germany has been set at 3.45% for 2022, which is the second highest level ever. We acknowledge ...
Underlying
Fresenius SE & Co. KGaA

Fresenius is a health care group providing products and services for dialysis, hospitals and outpatient medical care. Co. operates four business segments: Fresenius Medical Care; Fresenius Kabi; Fresenius Helios; and Fresenius Vamed. Fresenius Medical Care provides dialysis care and dialysis products for patients with chronic kidney failure. Fresenius Kabi is engaged in the provision of generic drugs, infusion therapies, clinical nutrition products, related medical devices and transfusion technology. Fresenius Vamed manages projects and provides services for hospitals and other health care facilities. Fresenius Helios is a private hospital operator which only operates in Germany.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Oliver Metzger

ResearchPool Subscriptions

Get the most out of your insights

Get in touch